Navigation Links
Paragon Bioservices Wins CMO Leadership Awards for Third Consecutive Year
Date:9/10/2013

BALTIMORE, Sept. 10, 2013 /PRNewswire/ -- Paragon Bioservices, a contract manufacturing organization whose expertise is the process development and manufacturing of biopharmaceuticals, announced today that it has been awarded the 2013 CMO Leadership Award for Quality and Reliability.

"We are very honored to receive this award from Life Science Leader -- especially because this is our third consecutive year," said Dr Marco Chacon, Paragon's CEO. "For more than twenty years, we have helped pharmaceutical and biotechnology companies and government agencies move forward in the development and manufacturing of vaccines (VLPs), monoclonal antibodies and therapeutic proteins.  We've completed two expansions in the past 4 years in order to constantly improve these capabilities.  Therefore, customer service, quality and reliability truly are key areas of focus at Paragon Bioservices.  The fact that we were recognized in the top 20% by more than 10,000 pharmaceutical executives is extremely gratifying to all of us at Paragon."

According to Jon Howland, Vice President of Publishing at Life Science Leader magazine, "These awards were conceived to better serve pharmaceutical and biopharmaceutical executives in their vetting process.  It gives them information on what their peers think of a wide range of CMOs and helps them to ultimately identify the leading CMOs in the industry."

ABOUT PARAGON BIOSERVICES, INC.
Paragon is a Contract Research & GMP Manufacturing Organization (CMO) delivering research, process development and manufacturing services. Paragon's focus is biopharmaceuticals -- including recombinant proteins, viral vectors, vaccines, VLPs, and bacteriophage. Our clients include pharmaceutical companies, biotechnology companies and federal agencies.  Our GMP space includes microbial and mammalian suites, fill-finish, and fully-segregated virus and BSL-3 facilities.

ABOUT LIFE SCIENCE LEADER
The vision of Life Science Leader is to be an essential business tool for life science executives. We are focused on staying connected with the key players and topics in the life science industry and making our magazine a must-read for our executive-level audience.  These CMO Leadership Awards are based on industry research and market intelligence conducted by Nice Insight -- a business that conducts the industry's largest annual outsourcing survey. 

MEDIA CONTACT:

Debbie James
Executive Vice President
Paragon Bioservices, Inc.
djames@paragonbioservices.com
(410)975-4050

 


'/>"/>
SOURCE Paragon Bioservices, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine
2. Biotechnology Market (Biopharmacy, Bioservices, Bioagri, Bioindustrial) Is Expected to Reach USD 414.5 Billion Globally in 2017: Transparency Market Research
3. Fisher BioServices Intensifies Commitment for Cell Therapy Companies in Clinical Trials and Approaching Commercialization
4. Nabsys Expands Leadership Team to Prepare for Commercialization of Novel DNA Positional Sequencing Technology
5. Berkeley Lab seeks to help US assert scientific leadership in critical materials
6. Auxilium Announces Appointments to Enhance Leadership Team
7. More than half of Americans doubt US global leadership in 2020
8. USC Marshall School of Business 6th Annual Leadership Summit
9. Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
10. BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
11. Innovation Leaders from Across Industries will Convene to Share Best Practices and Breakthrough Successes at Open Innovation Leadership Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, Inc. ... on its oral peptide drug candidates, PTG-100 and ... the European Crohn,s and Colitis Organization (ECCO).  The ... Barcelona, Spain from February 15 – ... preclinical data on Protagonist drug candidates PTG-100 and ...
(Date:2/16/2017)... WEST PALM BEACH, Fla. , Feb. 16, ... molecular diagnostics company revolutionizing the development of liquid ... that it has entered into an exclusive license ... who will distribute MDNA,s proprietary liquid biopsy test ... in South Korea . This ...
(Date:2/16/2017)... , February 16, 2017 ... the infusion of innovative telemedicine application, new and ... that are experiencing a boom worldwide. The healthcare ... advancement of technologies, services and new therapies for ... RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
(Date:2/16/2017)... , Feb. 16, 2017  Windtree Therapeutics, Inc. ... focusing on developing aerosolized KL4 surfactant therapies for ... preclinical influenza study showed that aerosolized KL4 surfactant ... a well-established preclinical animal model. The Company believes ... body of evidence that supports the role of ...
Breaking Biology Technology:
(Date:2/2/2017)... YORK , Feb. 2, 2017  EyeLock LLC, ... released a new white paper " What You Should ... The problem of ensuring user authenticity is a growing ... the authentication of users. However, traditional authentication schemes such ... Biometric authentication offers an elegant solution ...
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... Biopharm Reports has carried out a ... nuclear magnetic resonance spectroscopy (NMR). This involved the ... practices, developments, trends and end-user plans over the ... opportunities. These areas include growth in the use ... innovation requirements, hyphenated NMR techniques, main suppliers of ...
Breaking Biology News(10 mins):